USANA Health Sciences is a packaged foods company in the consumer defensive sector trading on NYSE, led by CEO Kevin G. Guest, with a market cap of $380.4M.
Upcoming earnings announcement for USANA Health Sciences
Past 11 earnings reports for USANA Health Sciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2025 | Q3 2025 | -$0.15Est: -$0.15 | 0.0% | $213.7MEst: $213.9M | -0.1% | |
| Jul 22, 2025 | Q2 2025 | $0.74Est: $0.54 | +37.0% | $235.8MEst: $225.2M | +4.7% | |
| Apr 22, 2025 | Q1 2025 | $0.73Est: $0.70 | +4.3% | $249.5MEst: $243.0M | +2.7% | |
| Feb 25, 2025 | Q4 2024 | $0.64Est: $0.49 | +30.6% | $213.6MEst: $208.8M | +2.3% | |
| Oct 22, 2024 | Q3 2024 | $0.56Est: $0.48 | +16.7% | $200.2MEst: $205.8M | -2.7% | |
| Jul 23, 2024 | Q2 2024 | $0.54Est: $0.65 | -16.9% | $212.9MEst: $221.0M | -3.7% | |
| Apr 30, 2024 | Q1 2024 | $0.86Est: $0.69 | +24.6% | $227.8MEst: $226.9M | +0.4% | |
| Feb 6, 2024 | Q4 2023 | $0.87Est: $0.52 | +67.3% | $221.1MEst: $212.8M | +3.9% | |
| Oct 24, 2023 | Q3 2023 | $0.59Est: $0.64 | -7.8% | $213.4MEst: $220.4M | -3.2% | — |
| Jul 25, 2023 | Q2 2023 | $0.89Est: $0.70 | +27.1% | $238.2MEst: $231.1M | +3.1% | |
| Apr 25, 2023 | Q1 2023 | $0.95Est: $0.77 | +23.4% | $248.4MEst: $240.2M | +3.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.